| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166616 Substituted alkanoic acids |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/18/2007 | WO2007006409A2 Herbicide-safener combination |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | US20070015805 Process for preparing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydroisoxazoline derivatives |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1742904A2 Substituted enaminones, their derivatives and uses thereof |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/17/2007 | CN1897939A Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/11/2007 | WO2007003294A1 3-[1-halo-1-aryl-methane-sulfonyl]- and 3-[1-halo-1-heteroaryl-methane-sulfonyl]-isoxazoline derivatives, method for the production thereof, and use of the same as herbicides and plant growth regulators |
| 01/11/2007 | WO2006102535A3 Sulfonyl containing compounds as cysteine protease inhibitors |
| 01/11/2007 | US20070010562 Nr1h4 nuclear receptor binding compounds |
| 01/11/2007 | DE102005031412A1 3-[1-Halo-1-aryl-methan-sulfonyl]-und 3-[1-Halo-1-heteroaryl-methan-sulfonyl]-isoxazolin-Derivate, Verfahren zu deren Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren 3- [1-halo-1-aryl-methane-sulfonyl] -and 3- [1-halo-1-heteroaryl-methane-sulfonyl] -isoxazolin-derivatives, processes for their preparation and use as herbicides and plant growth regulators |
| 01/11/2007 | CA2614239A1 Method for producing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| 01/11/2007 | CA2613962A1 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives |
| 01/10/2007 | EP1740556A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 01/10/2007 | CN1894240A 阿片受体拮抗剂 Opioid receptor antagonist |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 01/09/2007 | US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/04/2007 | WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | WO2007002172A2 Hiv-1 protease inhibitors |
| 01/04/2007 | CA2667445A1 Hiv-1 protease inhibitors |
| 01/04/2007 | CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/03/2007 | EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1293034C New gamma selective retinoids |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/02/2007 | US7157482 Antibacterial 1,3-oxazolidin-2-one derivatives |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 12/28/2006 | WO2006138510A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 12/28/2006 | WO2006136245A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
| 12/28/2006 | CA2608319A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/27/2006 | EP1735288A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735271A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 12/27/2006 | EP1735268A1 Opioid receptor antagonists |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1886133A Indole compounds |
| 12/26/2006 | US7153880 Substituted diphenyl heterocycles useful for treating HCV infection |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 12/21/2006 | US20060287535 Process for the manufacture of 1,2-benzisoxazole-3-methanesulphonamide |
| 12/21/2006 | US20060287306 Compounds to treat alzheimer's disease |
| 12/20/2006 | EP1732532A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor |
| 12/20/2006 | EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 12/19/2006 | US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 12/19/2006 | US7151075 Herbicides |
| 12/14/2006 | WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 12/14/2006 | WO2006131336A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| 12/14/2006 | WO2006131296A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 12/14/2006 | WO2006089177A3 Isoxazole combretastin derivatives for the treatment of disorders |
| 12/14/2006 | US20060281811 Synthesis of taxol enhancers |
| 12/14/2006 | US20060281777 Process for preparing crystalline form I of cabergoline |
| 12/14/2006 | CA2610373A1 Substituted n-benzo [d] isoxazol-3-ylamine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 12/14/2006 | CA2610310A1 Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands |
| 12/13/2006 | EP1731512A1 Isoxazoline-substituted benzamide compound and noxious organism control agent |
| 12/13/2006 | EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 12/13/2006 | EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use |
| 12/13/2006 | EP1730099A2 Mitotic kinesin inhibitors |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 12/13/2006 | EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/13/2006 | CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 12/13/2006 | CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 12/13/2006 | CN1289467C Dibenzylamine compound and medicinal use thereof |
| 12/12/2006 | CA2140106C Method of treating hyperproliferative vascular disease |
| 12/07/2006 | WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 12/07/2006 | US20060276642 Compounds to treat Alzheimer's disease |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/07/2006 | US20060276487 New compounds useful for DPP-IV enzyme inhibition |
| 12/07/2006 | DE102005026194A1 Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln N-substituted benzo [d] isoxazol-3-yl-amine derivatives and their use for the preparation of medicaments |
| 12/06/2006 | EP1728786A1 One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide |
| 12/06/2006 | EP1727542A2 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 12/06/2006 | EP1583748A4 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide |
| 12/06/2006 | CN1874769A Heterocyclic inhibitors of MEK and methods of use thereof |
| 12/05/2006 | US7144907 mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 12/05/2006 | US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 11/30/2006 | WO2006126751A1 New diaryl-isoxazole derivatives, and pharmaceutical compositions containing the same for the prevention and the treatment of cancers |
| 11/30/2006 | WO2006126514A1 Arylacetate derivative having isoxazole skeleton |
| 11/30/2006 | WO2006125370A1 Aromatic ether compounds,preparation and usage thereof |
| 11/30/2006 | WO2006076575B1 Substituted biaryl compounds as factor xia inhibitors |
| 11/30/2006 | WO2005089753A3 Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders |